Nevertheless, this study identified ZnT2 is a novel host-associated epithelial factor associated with mucosal inflammation and suggests manipulating the function of ZnT2 may offer new therapeutic strategies to treat specific intestinal infections and mucosal inflammation. Here, SLC30A2 is linked to digestive system infectious disorder.